0000899243-15-005201.txt : 20150922 0000899243-15-005201.hdr.sgml : 20150922 20150922165452 ACCESSION NUMBER: 0000899243-15-005201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150918 FILED AS OF DATE: 20150922 DATE AS OF CHANGE: 20150922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoCellular Therapeutics, Ltd. CENTRAL INDEX KEY: 0000822411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 931301885 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23622 CALABASAS ROAD STREET 2: SUITE 300 CITY: CALABASAS STATE: CA ZIP: 91302 BUSINESS PHONE: 818-264-2300 MAIL ADDRESS: STREET 1: 23622 CALABASAS ROAD STREET 2: SUITE 300 CITY: CALABASAS STATE: CA ZIP: 91302 FORMER COMPANY: FORMER CONFORMED NAME: Optical Molecular Imaging, Inc DATE OF NAME CHANGE: 20060202 FORMER COMPANY: FORMER CONFORMED NAME: PATCO INDUSTRIES LTD DATE OF NAME CHANGE: 19991025 FORMER COMPANY: FORMER CONFORMED NAME: REDWING VENTURES INC DATE OF NAME CHANGE: 19890705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singhvi Rahul CENTRAL INDEX KEY: 0001322731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35560 FILM NUMBER: 151119766 MAIL ADDRESS: STREET 1: 246 HOLLY DRIVE CITY: CHALFONT STATE: PA ZIP: 18914 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-18 0 0000822411 ImmunoCellular Therapeutics, Ltd. IMUC 0001322731 Singhvi Rahul C/O IMMUNOCELLULAR THERAPEUTICS, LTD. 23622 CALABASAS ROAD, SUITE 300 CALABASAS CA 91302 1 0 0 0 Common Stock 2015-09-18 4 A 0 10000 0.00 A 15000 D Common Stock 0.00 2015-09-18 4 A 0 10000 0.00 A 2019-09-18 Common Stock 10000 10000 D Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of Immunocellular Therapeutics, Ltd. common stock. The restricted stock unit are fully vested as of the grant date. Reflects the receipt of a restricted stock unit. Each restricted stock unit represents a contingent right to receive one (1) share of ImmunoCellular Therapeutics, Ltd. common stock. During the period from September 18, 2015 to September 18, 2019, the restricted stock unit may vest and become immediately exercisable if the average daily closing price of ImmunoCellular Therapeutics, Ltd. common stock on the NYSE MKT during any five (5) consecutive trading day period exceeds a closing $1.50 weighted average bid and ask price per share (as adjusted for any stock splits and the like). /s/ David Biener, Attorney-In-Fact 2015-09-22